Common Use

Dasatinib is a powerful second-generation tyrosine kinase inhibitor (TKI) used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). This targeted cancer therapy works by blocking the action of BCR-ABL and several other tyrosine kinases — abnormal proteins that drive uncontrolled cancer cell growth and proliferation. When you buy dasatinib online, you receive a proven oncology medication that is effective in both newly diagnosed CML patients and those who have developed resistance or intolerance to prior therapies, including imatinib. Dasatinib generic formulations provide the same pharmaceutical-grade quality as the original branded version (Sprycel), offering an accessible treatment option for patients requiring long-term tyrosine kinase inhibitor therapy.

Dosage and Direction

Take dasatinib exactly as prescribed by your oncologist, typically once daily with or without food. The standard dose for chronic phase CML in adults is 100 mg once daily, while accelerated phase CML, blast phase CML, or Ph+ ALL may require 140 mg once daily. Swallow the tablet whole with a full glass of water — do not crush, break, split, or chew the tablet, as this may alter drug absorption and increase the risk of side effects. Dosage adjustments may be necessary based on your blood counts, treatment response, and tolerability. Continue taking dasatinib for as long as your doctor recommends, even if you feel well, as discontinuing treatment prematurely may allow leukemia to progress.

Precautions

Before starting dasatinib, inform your doctor about your complete medical history, especially if you have heart problems (including QT prolongation or congestive heart failure), lung disease, liver impairment, or bleeding disorders. Regular monitoring of complete blood counts, liver function tests, and cardiac function is essential during treatment. Dasatinib may cause fluid retention, including pleural effusions (fluid around the lungs), which requires prompt medical evaluation. Women of childbearing potential should use effective contraception during treatment, as dasatinib may harm an unborn baby. Avoid grapefruit and grapefruit juice while taking this medication, as they can increase drug levels in your blood.

Contraindications

Do not use dasatinib if you are allergic to dasatinib or any of its inactive ingredients. Exercise particular caution if you have a history of bleeding disorders, severe pulmonary arterial hypertension, or significant cardiac conditions. Dasatinib is contraindicated during pregnancy and breastfeeding. Patients with severe hepatic impairment should be closely monitored and may require dose reduction. The concomitant use of strong CYP3A4 inducers should be avoided, as they may significantly reduce dasatinib effectiveness.

Possible Side Effect

Common side effects of dasatinib include fatigue, fluid retention (peripheral edema and pleural effusion), nausea, diarrhea, headache, musculoskeletal pain, and skin rash. Hematologic side effects such as myelosuppression — including neutropenia, thrombocytopenia, and anemia — are frequently observed and require regular blood monitoring. Serious but less common side effects may include pulmonary arterial hypertension (PAH), severe hemorrhage or bleeding complications, QT prolongation, and severe fluid retention affecting the lungs or pericardium. Report any unusual bruising, persistent shortness of breath, rapid weight gain, or signs of infection to your oncologist immediately.

Drug Interaction

Dasatinib is primarily metabolized by the CYP3A4 enzyme system, making it susceptible to significant drug interactions. Avoid concomitant use with strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, and ritonavir), as they can increase dasatinib blood levels and toxicity. Strong CYP3A4 inducers (such as rifampin, phenytoin, carbamazepine, and St. John's Wort) can substantially decrease dasatinib levels and reduce its anticancer efficacy. Do not consume grapefruit or grapefruit products during treatment. Acid-reducing agents, including proton pump inhibitors, H2 blockers, and antacids, may significantly interfere with dasatinib absorption and should be used with caution or avoided. Always inform your oncologist about all medications and supplements you are taking.

Missed Dose

If you miss a dose of dasatinib, take it as soon as you remember on the same day. If it is already close to the time of your next scheduled dose, skip the missed one and resume your regular dosing schedule. Do not take a double dose to make up for the one you missed. Maintaining consistent daily dosing is important for optimal treatment outcomes. Contact your healthcare team if you frequently miss doses.

Overdose

Symptoms of dasatinib overdose may include severe fatigue, dangerously low blood counts (myelosuppression), abnormal heart rhythms, or excessive fluid retention. There is no specific antidote for dasatinib overdose. If overdose is suspected, seek immediate emergency medical assistance. Treatment is supportive and may include close monitoring of hematologic parameters, cardiac function, and fluid balance.

Storage

Store dasatinib at controlled room temperature between 20–25°C (68–77°F), away from excessive moisture and direct light. Keep the tablets in their original container with the cap tightly closed. Store out of the reach of children and pets. Do not use dasatinib past its expiration date.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.